A Multidisciplinary Weight Loss Program at AUB-MC
NCT04194424 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2025-01-29
Summary
The current project aims at evaluating the feasibility and efficacy of a multi-disciplinary weight loss program, using an innovative and simple dietary intervention at the American University of Beirut Medical Center (AUB-MC). Such intervention is expected to enhance patients' compliance and adherence to lifestyle changes. In addition, the program includes supervised exercise sessions and behavioral therapy. Therefore, our project proposes an evidence based approach to close the obesity treatment gaps.
Conditions
Interventions
- OTHER
-
Multidisciplinary weight loss program
Diet and behavioral therapy,and supervised exercise sessions
- OTHER
-
Standard Care
General lifestyle tips
- DRUG
-
Metformin Hcl 850Mg Tab
1 tablet, twice daily
Sponsors & Collaborators
-
American University of Beirut Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-08-15
- Primary Completion
- 2026-09-15
- Completion
- 2026-09-15
Countries
- Lebanon
Study Locations
More Related Trials
-
ORAL ANTIDIABETICS EFFECT ON VISCERAL FAT
NCT05032001 ·Status: UNKNOWN ·Phase: NA
-
Dose Ranging and Dose Frequency of LIPO-102
NCT00918814 ·Status: COMPLETED ·Phase: PHASE2
-
Study Exploring the Supportive Effect of Acarbose in Weight Management
NCT05934110 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
NCT07184632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity
NCT00134303 ·Status: COMPLETED ·Phase: PHASE4
-
An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity
NCT01096979 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
NCT06924320 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity
NCT01180465 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects
NCT02568319 ·Status: COMPLETED ·Phase: PHASE2
-
Semaglutide in Nonalcoholic Fatty Liver Disease
NCT05813249 ·Status: COMPLETED ·Phase: PHASE4
-
GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight
NCT04779697 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test Different Doses of BI 456906 in Patients With Obesity
NCT03591718 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat
NCT04144049 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
NCT05779644 ·Status: UNKNOWN ·Phase: NA
-
Study of Patients Being Treated With Anti-obesity Medication
NCT06790160 ·Status: RECRUITING
-
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
NCT04010786 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet
NCT05429593 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)
NCT07230119 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Zenoctil in Reducing Body Weight
NCT01423617 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Antiobesity Medications on Appetite and Appetite-related Hormones and Metabolites.
NCT06856928 ·Status: NOT_YET_RECRUITING
-
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RM-493 Administered to Healthy, Obese, Non-diabetic Volunteers
NCT02431442 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
NCT07142707 ·Status: RECRUITING ·Phase: PHASE1
-
First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity
NCT03015207 ·Status: COMPLETED ·Phase: PHASE1
-
Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
NCT03308721 ·Status: COMPLETED ·Phase: PHASE1
-
Personalized or Precision Medicine in the Dietary Approach to Obesity
NCT05420311 ·Status: UNKNOWN ·Phase: NA